Nadex Advertisement
Interactive Brokers Advertisement
Home > Boards > US OTC > Cannabis >

Nemus Bioscience, Inc. (NMUS)

Add NMUS Price Alert      Hide Sticky   Hide Intro
Moderator: MasterBlastr, Paulieme, miracleshappen, afterhoursearnings
Search This Board: 
Last Post: 7/28/2017 8:50:52 AM - Followers: 115 - Board type: Free - Posts Today: 2


 NEMUS BIOSCIENCE™ provides pharmaceutical research and development services focused on discovering, developing, and commercializing new chemical entities from a class of chemically diverse compounds. We develop novel and proprietary classes of product candidates that are designed to improve therapeutic options through enhanced chemical engineering that allow drug candidates to have more predictable bioavailability and pharmacokinetics leading to optimized efficacy and safety.

NEMUS Bioscience Inc., a Nevada corporation, is a SEC fully reporting company listed on the  under the symbol NMUS.

Company Website:

Filings and disclosure with Level 2 quotes:


(949) 396-0330


Nemus Bioscience (NMUS) Presentation (47 minutes):

Presentation at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City September 12th, 2016:


Major press releases:

A Sit Down With Nemus Bioscience; Cannabinoids In Focus Feb. 1, 2017 11:06 AM ET Nemus Bioscience, Inc. (NMUS)  

Nemus Bioscience Announces Milestones in the Development of Fully Synthetic Clinical-Grade Active Pharmaceutical Ingredient (API) for Drug Candidates NB1111 and NB2111 and Formulation Contract with AMRI and Catalent Pharma Solutions -

Cannabinoid Drug Advancements Take Off After Quantum Shift in U.S. Drug Policy

Nemus Bioscience Announces Presentation of NB1111 Impact on Intraocular Pressure (IOP) in Normotensive Ocular Model at the National Meeting of the American Association of Pharmaceutical Scientists (AAPS)


Nemus Bioscience Announces Enhanced Ocular Tissue Concentration by the Proprietary Prodrug of Tetrahydrocannabinol (NB1111) - Associated With a Superior Decline in Intra-Ocular Pressure (IOP) in an Animal Model


Nemus Bioscience, Inc. Announces Letter of Intent to License Biosynthetic Technology to Manufacture Its Proprietary Cannabinoid Molecules From Teewinot Life Sciences Corp.

NEMUS Bioscience Identifies Unique Cannabidiol (CBD) Derivative as a Lead Candidate in Its Neuropathy-Related Pain Management Program 

CANNAINVESTOR Magazine Top 20 Cannabis Stocks 


NEMUS Bioscience CEO to Present at the 28th Annual ROTH Conference 


NEMUS Bioscience, Inc. Signs Agreement With Albany Molecular Research Inc. (AMRI) to Manufacture Cannabinoid-Based Active Pharmaceutical Ingredients 


NEMUS Bioscience Prodrug of THC (NB1111) Completes Validation Stage of Glaucoma Testing and Development 


Nemus Enters Into Research Agreement With the University of Mississippi to Develop Cannabinoid-Based Therapies for Chemotherapy-Induced Peripheral Neuropathy (CIPN) 


NMUS Security Details

Share Structure - as of Feb 1, 2017

Authorized Shares: 236,000,000
Outstanding Shares: 
      - Restricted  13,494,621
    - Unrestricted   8,943,542

           - Float   5,005,713 a/o Mar 23, 2016 
   Par Value 0.001

Transfer Agent: Clear Trust, LLC

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NMUS News: Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) 07/11/2017 09:10:58 AM
NMUS News: Current Report Filing (8-k) 07/11/2017 09:05:23 AM
NMUS News: Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) 05/12/2017 04:49:26 PM
NMUS News: Quarterly Report (10-q) 05/12/2017 04:48:59 PM
NMUS News: Current Report Filing (8-k) 05/04/2017 05:20:54 PM
#2322  Sticky Note From a wise man, copy and pasted for sticky. afterhoursearnings 05/27/17 02:05:41 PM
#2002  Sticky Note $NMUS $20 Million Dollar Bankroll and a Solid The Rainmaker 05/06/17 05:55:18 PM
#1508  Sticky Note $NMUS / $GWPH BEST IN CLASS Oncology Potential Underrated Momostocktrades 03/06/17 07:59:34 PM
#2633   Good read but the 505(b)(2) for NB1222 is Closewatcher 07/28/17 08:50:51 AM
#2632   Vinpat, I stayed up all night AntonChigurh 07/28/17 02:45:37 AM
#2631   lmao go team frontloaded! TrueTrades 07/27/17 05:47:02 PM
#2630   if you need liquidity AntonChigurh 07/27/17 01:36:25 PM
#2629   good things come to those who wait AntonChigurh 07/27/17 01:34:51 PM
#2628   Holding 52,000 shares until 2020. WE AINT GOING ANYWHERE. Closewatcher 07/27/17 12:13:48 PM
#2627   Don't let go of the Rope.Its hard to AntonChigurh 07/27/17 12:00:22 PM
#2626   Scratch that. month to month, and quarter to quarter. Closewatcher 07/27/17 10:59:13 AM
#2625   Its as if there are 6 people in Closewatcher 07/27/17 10:46:00 AM
#2623   Only a bit surprised that people would buy cjarmstrong 07/20/17 10:27:57 PM
#2622   I agree that they shouldn't be AntonChigurh 07/19/17 11:27:23 PM
#2621   I don't know what's going on with Schneider. cjarmstrong 07/19/17 05:34:24 PM
#2620   i don't think what I brought to light AntonChigurh 07/19/17 01:48:58 AM
#2619   I hope this pulls a VP*R and makes jjr04001 07/18/17 10:28:19 PM
#2618   the info you brought to light was enough TrueTrades 07/18/17 04:58:43 PM
#2617   'The .25's are trickling out' Sounds very fake news. AntonChigurh 07/18/17 04:24:04 PM
#2616   what else did you find about schneider AntonChigurh 07/18/17 02:21:43 PM
#2615   i think i get the game here from TrueTrades 07/18/17 02:02:07 PM
#2614   felt this way long time...very hard to plan Mandofellow 07/18/17 01:47:26 PM
#2613   When do we expect FDA trials and approval? Ryan R 07/18/17 10:39:34 AM
#2612   So bizarre the complete lack of volume in Closewatcher 07/18/17 08:30:49 AM
#2611   hi all...hanging always..not so easy...can anyone offer Mandofellow 07/17/17 01:13:47 PM
#2610   Very strong. AntonChigurh 07/17/17 09:47:48 AM
#2609 olsenbk 07/17/17 09:33:48 AM
#2608   Coke dealers, heroine dealers. Its all the same. Closewatcher 07/14/17 08:43:37 AM
#2607   Umm, part of the thesis here AntonChigurh 07/13/17 01:18:28 PM
#2606   block trade AntonChigurh 07/13/17 01:17:35 PM
#2605   How Weed Triggers The Endocannabinoid System To Help Paulieme 07/12/17 11:46:54 PM
#2604   Very much appreciated TrueTrades 07/12/17 05:45:35 PM
#2603   Really not concerning. Closewatcher 07/12/17 05:26:11 PM
#2602   Spoke with Schneider Brothers Newport AntonChigurh 07/12/17 01:35:28 PM
#2601   I would like to believe that AntonChigurh 07/12/17 11:25:13 AM
#2600   Seems like a witch hunt. Wouldn't be too Closewatcher 07/12/17 08:51:54 AM
#2599   Seems like a witch hunt. Wouldn't be too Closewatcher 07/12/17 08:51:54 AM
#2598   My educated guess is they negotiated the deal Vinpat 07/12/17 12:39:22 AM
#2597   i agree TrueTrades 07/11/17 11:04:42 PM
#2596   Lykos was the once who brought the deal AntonChigurh 07/11/17 10:50:59 PM
#2595   oh lord! TrueTrades 07/11/17 10:07:57 PM
#2594   i saw that philippe name in those horrid TrueTrades 07/11/17 10:07:06 PM
#2593   more Schneider/Philippe Ayme-Jouve findings AntonChigurh 07/11/17 09:45:59 PM
#2592   'schneider just doesnt look completely on the up AntonChigurh 07/11/17 09:12:34 PM
#2591   asset and wealth management could very well mean TrueTrades 07/11/17 08:50:00 PM
#2590   Ya, that had been talked about before AntonChigurh 07/11/17 08:34:11 PM
#2589   i dont like anything im digging up TrueTrades 07/11/17 08:31:01 PM
#2588   the structure of Schneider AntonChigurh 07/11/17 08:16:54 PM
#2587   hmm interesting AntonChigurh 07/11/17 07:56:41 PM
#2586   bloomberg says TrueTrades 07/11/17 07:34:00 PM
#2585   im just assuming they report all figures except TrueTrades 07/11/17 07:06:43 PM
#2584   TrueTrades, how are you calculating that? Where does AntonChigurh 07/11/17 06:39:00 PM
#2583   Jul. 11, 2017 2:13 PM ET Paulieme 07/11/17 03:34:50 PM